BC-ADM Exam (Board Certified – Advanced Diabetes
Management) ACTUAL EXAM ALL QUESTIONS AND
CORRECT ANSWERS LATEST UPDATE THIS YEAR-
JUST RELEASED.pdf
1. A 62-year-old with T2DM on metformin and glipizide presents with confusion
and diaphoresis. Glucose is 52 mg/dL. The patient is conscious but drowsy. What is
the priority intervention?
A. Administer 1 mg Glucagon IM immediately.
B. Administer 15g of oral glucose gel buccally.
C. Start an IV and administer D50W.
D. Have the patient drink 4 oz of orange juice.
Answer: B. Administer 15g of oral glucose gel buccally.
Explanation: The patient is conscious (though drowsy) and can protect their airway. The
"Rule of 15" using oral glucose gel is the safest and most effective first step. Glucagon (A)
is for unconscious patients or those unable to swallow. IV Dextrose (C) is aggressive and
usually reserved for severe hypoglycemia with loss of consciousness or failure of oral
therapy. Orange juice (D) carries a higher aspiration risk in a drowsy patient compared to
gel placed in the buccal pouch.
2. Which medication requires a baseline heart failure assessment and periodic
monitoring due to a known risk of hospitalization for heart failure?
A. Empagliflozin (Jardiance)
B. Pioglitazone (Actos)
C. Semaglutide (Ozempic)
D. Linagliptin (Tradjenta)
Answer: B. Pioglitazone (Actos).
*Explanation: Thiazolidinediones (TZDs) like Pioglitazone cause fluid retention and are
contraindicated in patients with NYHA Class III or IV heart failure. SGLT2 inhibitors (A)
actually reduce the risk of heart failure hospitalization. GLP-1 RAs (C) and DPP-4
inhibitors (D) are generally weight-neutral or beneficial regarding HF risk, except for
Saxagliptin which carries a specific HF warning.*
,3. A patient on an insulin pump reports a blood glucose of 350 mg/dL and a CGM
reading of "LOW." What is the most likely cause of this discrepancy?
A. The pump site is infected.
B. The patient recently took Acetaminophen.
C. The interstitial fluid glucose is lagging behind blood glucose.
D. The sensor is incorrectly calibrated due to a low battery.
Answer: C. The interstitial fluid glucose is lagging behind blood glucose.
*Explanation: This is a classic sign of "sensor lag" combined with a potential pump
occlusion or severe dehydration. When blood glucose rises rapidly (due to pump
failure), the interstitial fluid (where CGM reads) takes 10-20 minutes to catch up, causing
a false "LOW" alarm while the fingerstick is high. Acetaminophen (B) falsely elevates
CGM readings in older sensors, not lowers them.*
4. Which of the following is the earliest detectable sign of diabetic nephropathy in
a urinalysis?
A. Macroalbuminuria (>300 mg/g creatinine)
B. Elevated serum creatinine
C. Microalbuminuria (30-300 mg/g creatinine)
D. Hematuria
*Answer: C. Microalbuminuria (30-300 mg/g creatinine).*
Explanation: Diabetic kidney disease begins with hyperfiltration and microalbuminuria
before the GFR declines. Serum creatinine (B) does not rise until significant kidney function
(roughly 50%) is lost. Macroalbuminuria (A) is a later, more severe stage.
5. A patient with T2DM and ASCVD is being transitioned from insulin to a GLP-1
RA. The patient asks if they can stop their statin. The BC-ADM should respond:
A. "Yes, the GLP-1 will manage your cholesterol now."
B. "No, statin therapy is independent of glucose control for ASCVD risk reduction."
C. "You can reduce the statin dose by half."
D. "We will check your lipids in 6 months and decide then."
Answer: B. "No, statin therapy is independent of glucose control for ASCVD risk reduction."
*Explanation: The cardiovascular benefit of GLP-1 RAs is independent of the lipid-
lowering benefit of statins. Current guidelines recommend high-intensity statin therapy
for most patients with diabetes and established ASCVD regardless of baseline LDL or
A1C.*
6. A patient with T1DM is planning a 90-minute high-intensity interval training
(HIIT) session. What is the most likely immediate glucose response during the
workout?
,A. Severe hypoglycemia within 10 minutes.
B. Gradual decrease in glucose requiring a 15g snack.
C. Transient hyperglycemia followed by late-onset hypoglycemia.
D. No change in glucose due to anaerobic metabolism.
Answer: C. Transient hyperglycemia followed by late-onset hypoglycemia.
*Explanation: High-intensity anaerobic exercise stimulates counter-regulatory hormones
(epinephrine, cortisol) which cause the liver to dump glucose, often resulting in a spike
during the activity. However, increased insulin sensitivity persists for 12-24 hours post-
exercise, leading to a high risk of delayed nocturnal hypoglycemia.*
7. A patient with T2DM and an eGFR of 25 mL/min/1.73m² (Stage 4 CKD) asks
about starting Metformin. What is the appropriate response?
A. Start Metformin 500 mg daily; it is safe at any eGFR.
B. Do not start Metformin; the risk of lactic acidosis outweighs benefits.
C. Start Metformin ER 2000 mg daily for maximum benefit.
D. Start Metformin but monitor B12 levels monthly.
Answer: B. Do not start Metformin; the risk of lactic acidosis outweighs benefits.
*Explanation: According to FDA labeling (updated 2016), Metformin is contraindicated in
patients with an eGFR below 30 mL/min/1.73 m². In patients with eGFR 30-45, dose
reduction is required, but initiation below 30 is not recommended.*
8. Which of the following insulin regimens is most likely to cause significant
weight gain compared to basal-only therapy?
A. Basal insulin (Glargine) only.
B. Basal-Bolus (Glargine/Lispro).
C. Pre-mixed 70/30 insulin twice daily.
D. Insulin Degludec with Liraglutide (IDegLira).
Answer: B. Basal-Bolus (Glargine/Lispro).
*Explanation: While all insulins cause weight gain, intensive insulin therapy (Basal-Bolus)
which covers both fasting and prandial needs exposes the patient to higher total daily
doses of insulin, leading to more lipogenesis and weight gain. Pre-mixed insulin (C) also
causes gain, but fixed-ratio combinations (D) with GLP-1 are weight-neutral or weight-
loss promoting.*
9. A patient presents with a painless, punched-out ulcer on the plantar surface of
the foot, surrounded by thick callus. There is no surrounding erythema. What is
the most likely etiology?
A. Venous stasis ulcer.
B. Arterial insufficiency ulcer.
, C. Neuropathic ulcer.
D. Charcot arthropathy.
Answer: C. Neuropathic ulcer.
Explanation: The description of "painless" and "surrounded by callus" is pathognomonic for
a neuropathic ulcer caused by repetitive pressure on an insensate foot. Venous ulcers (A)
are wet, shallow, and on the medial malleolus. Arterial ulcers (B) are painful, distal, and
have a "punched out" appearance but lack callus and are exquisitely painful unless
neuropathy is also present.
10. Which medication is associated with a "Black Box Warning" for thyroid C-cell
tumors?
A. Dapagliflozin (Farxiga)
B. Liraglutide (Victoza)
C. Sitagliptin (Januvia)
D. Glimepiride (Amaryl)
Answer: B. Liraglutide (Victoza).
*Explanation: All GLP-1 receptor agonists carry a boxed warning regarding the risk of
medullary thyroid carcinoma (MTC) based on rodent studies. They are contraindicated in
patients with a personal or family history of MTC or MEN2 syndrome.*
11. A 35-year-old with T1DM has an A1C of 6.1% but reports frequent episodes of
shakiness and sweating between 2:00 AM and 4:00 AM. Which CGM metric should
the BC-ADM focus on improving first?
A. Time Above Range (TAR) >250 mg/dL.
B. Time In Range (TIR) 70-180 mg/dL.
C. Time Below Range (TBR) <70 mg/dL.
D. Coefficient of Variation (CV).
*Answer: C. Time Below Range (TBR) <70 mg/dL.*
*Explanation: The clinical priority in diabetes management safety hierarchy is: 1)
Eliminate Level 2/3 Hypoglycemia, 2) Reduce Level 1 Hypoglycemia (TBR), 3) Reduce
Hyperglycemia. A "perfect" A1C of 6.1% driven by hypoglycemia is dangerous and
indicative of hypoglycemia unawareness. Reducing basal insulin to eliminate nocturnal
lows is the first step.*
12. A patient with T2DM, HTN, and an A1C of 8.2% on Metformin has a urine ACR
of 450 mg/g. Which medication class provides the most compelling dual benefit
for this specific patient?
A. Sulfonylurea
B. SGLT2 Inhibitor
Management) ACTUAL EXAM ALL QUESTIONS AND
CORRECT ANSWERS LATEST UPDATE THIS YEAR-
JUST RELEASED.pdf
1. A 62-year-old with T2DM on metformin and glipizide presents with confusion
and diaphoresis. Glucose is 52 mg/dL. The patient is conscious but drowsy. What is
the priority intervention?
A. Administer 1 mg Glucagon IM immediately.
B. Administer 15g of oral glucose gel buccally.
C. Start an IV and administer D50W.
D. Have the patient drink 4 oz of orange juice.
Answer: B. Administer 15g of oral glucose gel buccally.
Explanation: The patient is conscious (though drowsy) and can protect their airway. The
"Rule of 15" using oral glucose gel is the safest and most effective first step. Glucagon (A)
is for unconscious patients or those unable to swallow. IV Dextrose (C) is aggressive and
usually reserved for severe hypoglycemia with loss of consciousness or failure of oral
therapy. Orange juice (D) carries a higher aspiration risk in a drowsy patient compared to
gel placed in the buccal pouch.
2. Which medication requires a baseline heart failure assessment and periodic
monitoring due to a known risk of hospitalization for heart failure?
A. Empagliflozin (Jardiance)
B. Pioglitazone (Actos)
C. Semaglutide (Ozempic)
D. Linagliptin (Tradjenta)
Answer: B. Pioglitazone (Actos).
*Explanation: Thiazolidinediones (TZDs) like Pioglitazone cause fluid retention and are
contraindicated in patients with NYHA Class III or IV heart failure. SGLT2 inhibitors (A)
actually reduce the risk of heart failure hospitalization. GLP-1 RAs (C) and DPP-4
inhibitors (D) are generally weight-neutral or beneficial regarding HF risk, except for
Saxagliptin which carries a specific HF warning.*
,3. A patient on an insulin pump reports a blood glucose of 350 mg/dL and a CGM
reading of "LOW." What is the most likely cause of this discrepancy?
A. The pump site is infected.
B. The patient recently took Acetaminophen.
C. The interstitial fluid glucose is lagging behind blood glucose.
D. The sensor is incorrectly calibrated due to a low battery.
Answer: C. The interstitial fluid glucose is lagging behind blood glucose.
*Explanation: This is a classic sign of "sensor lag" combined with a potential pump
occlusion or severe dehydration. When blood glucose rises rapidly (due to pump
failure), the interstitial fluid (where CGM reads) takes 10-20 minutes to catch up, causing
a false "LOW" alarm while the fingerstick is high. Acetaminophen (B) falsely elevates
CGM readings in older sensors, not lowers them.*
4. Which of the following is the earliest detectable sign of diabetic nephropathy in
a urinalysis?
A. Macroalbuminuria (>300 mg/g creatinine)
B. Elevated serum creatinine
C. Microalbuminuria (30-300 mg/g creatinine)
D. Hematuria
*Answer: C. Microalbuminuria (30-300 mg/g creatinine).*
Explanation: Diabetic kidney disease begins with hyperfiltration and microalbuminuria
before the GFR declines. Serum creatinine (B) does not rise until significant kidney function
(roughly 50%) is lost. Macroalbuminuria (A) is a later, more severe stage.
5. A patient with T2DM and ASCVD is being transitioned from insulin to a GLP-1
RA. The patient asks if they can stop their statin. The BC-ADM should respond:
A. "Yes, the GLP-1 will manage your cholesterol now."
B. "No, statin therapy is independent of glucose control for ASCVD risk reduction."
C. "You can reduce the statin dose by half."
D. "We will check your lipids in 6 months and decide then."
Answer: B. "No, statin therapy is independent of glucose control for ASCVD risk reduction."
*Explanation: The cardiovascular benefit of GLP-1 RAs is independent of the lipid-
lowering benefit of statins. Current guidelines recommend high-intensity statin therapy
for most patients with diabetes and established ASCVD regardless of baseline LDL or
A1C.*
6. A patient with T1DM is planning a 90-minute high-intensity interval training
(HIIT) session. What is the most likely immediate glucose response during the
workout?
,A. Severe hypoglycemia within 10 minutes.
B. Gradual decrease in glucose requiring a 15g snack.
C. Transient hyperglycemia followed by late-onset hypoglycemia.
D. No change in glucose due to anaerobic metabolism.
Answer: C. Transient hyperglycemia followed by late-onset hypoglycemia.
*Explanation: High-intensity anaerobic exercise stimulates counter-regulatory hormones
(epinephrine, cortisol) which cause the liver to dump glucose, often resulting in a spike
during the activity. However, increased insulin sensitivity persists for 12-24 hours post-
exercise, leading to a high risk of delayed nocturnal hypoglycemia.*
7. A patient with T2DM and an eGFR of 25 mL/min/1.73m² (Stage 4 CKD) asks
about starting Metformin. What is the appropriate response?
A. Start Metformin 500 mg daily; it is safe at any eGFR.
B. Do not start Metformin; the risk of lactic acidosis outweighs benefits.
C. Start Metformin ER 2000 mg daily for maximum benefit.
D. Start Metformin but monitor B12 levels monthly.
Answer: B. Do not start Metformin; the risk of lactic acidosis outweighs benefits.
*Explanation: According to FDA labeling (updated 2016), Metformin is contraindicated in
patients with an eGFR below 30 mL/min/1.73 m². In patients with eGFR 30-45, dose
reduction is required, but initiation below 30 is not recommended.*
8. Which of the following insulin regimens is most likely to cause significant
weight gain compared to basal-only therapy?
A. Basal insulin (Glargine) only.
B. Basal-Bolus (Glargine/Lispro).
C. Pre-mixed 70/30 insulin twice daily.
D. Insulin Degludec with Liraglutide (IDegLira).
Answer: B. Basal-Bolus (Glargine/Lispro).
*Explanation: While all insulins cause weight gain, intensive insulin therapy (Basal-Bolus)
which covers both fasting and prandial needs exposes the patient to higher total daily
doses of insulin, leading to more lipogenesis and weight gain. Pre-mixed insulin (C) also
causes gain, but fixed-ratio combinations (D) with GLP-1 are weight-neutral or weight-
loss promoting.*
9. A patient presents with a painless, punched-out ulcer on the plantar surface of
the foot, surrounded by thick callus. There is no surrounding erythema. What is
the most likely etiology?
A. Venous stasis ulcer.
B. Arterial insufficiency ulcer.
, C. Neuropathic ulcer.
D. Charcot arthropathy.
Answer: C. Neuropathic ulcer.
Explanation: The description of "painless" and "surrounded by callus" is pathognomonic for
a neuropathic ulcer caused by repetitive pressure on an insensate foot. Venous ulcers (A)
are wet, shallow, and on the medial malleolus. Arterial ulcers (B) are painful, distal, and
have a "punched out" appearance but lack callus and are exquisitely painful unless
neuropathy is also present.
10. Which medication is associated with a "Black Box Warning" for thyroid C-cell
tumors?
A. Dapagliflozin (Farxiga)
B. Liraglutide (Victoza)
C. Sitagliptin (Januvia)
D. Glimepiride (Amaryl)
Answer: B. Liraglutide (Victoza).
*Explanation: All GLP-1 receptor agonists carry a boxed warning regarding the risk of
medullary thyroid carcinoma (MTC) based on rodent studies. They are contraindicated in
patients with a personal or family history of MTC or MEN2 syndrome.*
11. A 35-year-old with T1DM has an A1C of 6.1% but reports frequent episodes of
shakiness and sweating between 2:00 AM and 4:00 AM. Which CGM metric should
the BC-ADM focus on improving first?
A. Time Above Range (TAR) >250 mg/dL.
B. Time In Range (TIR) 70-180 mg/dL.
C. Time Below Range (TBR) <70 mg/dL.
D. Coefficient of Variation (CV).
*Answer: C. Time Below Range (TBR) <70 mg/dL.*
*Explanation: The clinical priority in diabetes management safety hierarchy is: 1)
Eliminate Level 2/3 Hypoglycemia, 2) Reduce Level 1 Hypoglycemia (TBR), 3) Reduce
Hyperglycemia. A "perfect" A1C of 6.1% driven by hypoglycemia is dangerous and
indicative of hypoglycemia unawareness. Reducing basal insulin to eliminate nocturnal
lows is the first step.*
12. A patient with T2DM, HTN, and an A1C of 8.2% on Metformin has a urine ACR
of 450 mg/g. Which medication class provides the most compelling dual benefit
for this specific patient?
A. Sulfonylurea
B. SGLT2 Inhibitor
